Intellia Therapeutics (NTLA)'s 30-day implied volatility (IV30) was 67.6% at the close on October 27, 2026, down from 69.9% the day before, against a 52-week range of 58.3% to 150.4%. Its 20-day historical volatility was 68.4%.
Data as of October 27, 2026.